[1] Jan J, Osho A, Murphy C C, et al. Gender, age, racial and ethnic disparities in clinical trial enrollment for primary liver cancer. Gastroenterology, 2022, 163(1):14-20. [2] 郑希彦,杜飞,林志群,等.肝细胞癌进展:代谢综合征相关危险因素研究.实用肝脏病杂志,2022,25(6):877-880. [3] Shuang L, Hui L, Lei G, et al. Tumor size affects efficacy of adjuvant transarterial chemoembolization in patients with hepatocellular carcinoma and microvascular invasion. Oncologist, 2019, 24(4):513-520. [4] 雷海科, 李小升, 赵玉兰, 等. 原发性肝癌患者生存预后及影响因素分析(附3106例报告). 中华消化外科杂志, 2020, 19(2):179-184. [5] 孔杰, 李辉, 曾雪燕,等. 原发性肝癌区域淋巴结转移的临床病理特点及预后分析. 中华肿瘤防治杂志, 2022,29(4):290-295,e301. [6] Wang J, Zhao J P, Wang J J, et al. The impact of bile leakage on long-term prognosis in primary liver cancers after hepatectomy: A propensity-score-matched study. Asian J Surg, 2019, 43(5):603-612. [7] 中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版). 中华消化外科杂志, 2017,25(12):886-895. [8] Envelope H R P, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol, 2022, 77(6):1598-1606. [9] Zhou Q, Chen L, Chen S, et al. Postsurgical multiple-sites sampling procedure for the precise detection of microvascular invasion of hepatocellular carcinoma. J Clin Oncol, 2019, 37(15):15657-15657. [10] Ping X Z,Zong T C, Zhen Y G, et al. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis - ScienceDirect. HPB, 2019, 21( 12):1687-1696. [11] Nan Y, Xu X, Gao Y, et al. Consensus on the secondary prevention of primary liver cancer . Hepatol Int, 2022,15(6):1289-1300. [12] Zhou Z, Qi L, Mo Q, et al. Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis. J Cancer, 2021, 12(15):4455-4462. [13] Burton A, Tataru D, Driver R J, et al. Primary liver cancer in the UK: Incidence, incidence-based mortality and survival by subtype, sex and nation. JHEP Rep, 2021, 3(4):100232-100232. [14] Shimada Y, Muneoka Y, Nagahashi M, et al. BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer. Sci Rep, 2019, 9(1):2466-2466. [15] Torphy R J, Friedman C, Halpern A, et al. Risk factors for post-hepatectomy liver failure following resection of primary hepatobiliary versus metastatic cancer. HPB, 2019, 21(1):65-65. [16] Tan E, Sandroussi C . Liver resection in elderly patients over the age of 70 with primary liver cancer: A retrospective analysis. J Clin Oncol, 2019, 37(15):15647-15647. [17] Nitta H, Allard M A, Sebagh M, et al. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation. Surgery, 2019,165(6):1168-1175. [18] Yang Y, Lin K, Liu L, et al. Impact of preoperative TACE on incidences of microvascular invasion andlong‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis. Cancer Med, 2021, 10(6):2100-2111. [19] Sehmbey G, Parveen P, Xiong M, et al. S1083assessing predictors of microvascular invasion of HCC at explant in liver transplantation. Am J Gastroenterol, 2020, 115(1):548-550. [20] 丛文铭, 吴孟超. 努力提高我国肝癌微血管侵犯的精细化诊断和个体化治疗水平. 中华肝胆外科杂志,2019,25(10):721-724. |